Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit (Q44539087)

3 December 2017

Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit (English)

1 reference

3 December 2017

0 references

1 reference

1

1 reference

3 December 2017

7

Dean D Metcalfe

1 reference

3 December 2017

Knut Brockow

2

1 reference

3 December 2017

Claudio D'Ambrosio

3

1 reference

3 December 2017

Arnold S Kirshenbaum

4

1 reference

3 December 2017

Yongsheng Ma

5

1 reference

3 December 2017

B Jack Longley

6

1 reference

3 December 2017

1 August 2003

1 reference

3 December 2017

Experimental Hematology

1 reference

3 December 2017

31

1 reference

3 December 2017

686-692

1 reference

3 December 2017

8

1 reference

Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900112-7

7 January 2021

Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900112-7

7 January 2021

Indolinone derivatives inhibit constitutively activated KIT mutants and kill neoplastic mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900112-7

7 January 2021

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900112-7

7 January 2021

Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900112-7

7 January 2021

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900112-7

7 January 2021

The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900112-7

7 January 2021

Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900112-7

7 January 2021

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900112-7

7 January 2021

Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900112-7

7 January 2021

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900112-7

7 January 2021

c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900112-7

7 January 2021

Activating c-kit gene mutations in human germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900112-7

7 January 2021

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900112-7

7 January 2021

Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900112-7

7 January 2021

New approaches to therapy for mastocytosis. A case for treatment with kit kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900112-7

7 January 2021

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900112-7

7 January 2021

Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900112-7

7 January 2021

10.1016/S0301-472X(03)00112-7

Identifiers

DOI

1 reference

3 December 2017

1 reference